Mercer Global Advisors’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-47,560
Closed -$1.17M 2062
2023
Q2
$1.17M Buy
47,560
+7,831
+20% +$192K ﹤0.01% 895
2023
Q1
$924K Buy
39,729
+3,865
+11% +$89.9K ﹤0.01% 944
2022
Q4
$908K Buy
35,864
+1,414
+4% +$35.8K ﹤0.01% 960
2022
Q3
$664K Buy
+34,450
New +$664K ﹤0.01% 1017